Nexentis Technologies NXTS
NASDAQ NXTS
$1.69 +0.02 (+1.20%)
At close: Sep 9, 2026 · 4:00 PM EDT

Nexentis Technologies (NXTS) EBT (2019 - 2026)

Nexentis Technologies (NXTS) posted EBT of -$11.2 million for Q2 2026, down 2136.98% on a QoQ basis from $549000.0 in Q4 2025, and down 154.91% year-over-year from $20.4 million in Q2 2025.

Analysis

Nexentis Technologies (NXTS) EBT (2019 - 2026) Analysis & Trends

Nexentis Technologies has reported EBT for 8 years, with the latest figure at -$11.2 million in Q2 2026.

  • On a quarterly basis, EBT fell 154.91% year-over-year to -$11.2 million in Q2 2026; TTM through Jun 2026 was -$16.3 million, a 145.41% decrease from a year earlier, with the FY2025 full-year figure at -$3.6 million, up 16.35% from the prior year.
  • EBT was -$11.2 million for Q2 2026 at Nexentis Technologies, down from $549000.0 in the prior quarter.
  • The five-year high for EBT was $549000.0 in Q4 2025, with the low at -$11.2 million in Q2 2026.
  • Average EBT over 5 years is -$2.0 million, with a median of -$1.3 million recorded in 2022.
  • The sharpest annual moves came in 2022 and 2025: EBT slumped 445.07% in 2022, then jumped 350.68% in 2025.
  • Over 5 years, EBT stood at -$1.4 million in 2022, then sank by 49.53% to -$2.1 million in 2023, then surged by 89.75% to -$219000.0 in 2024, then surged by 350.68% to $549000.0 in 2025, then plunged by 2136.98% to -$11.2 million in 2026.
  • The last three EBT figures came in at -$11.2 million (Q2 2026), $549000.0 (Q4 2025), and -$1.3 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 2.77 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -10.25 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 1.39 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 1.53 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 542.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -767.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 177.81 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 132.40 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -294.56 Mn
10 Nexentis Technologies 1.40 Mn -7.48 Mn - -11.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.18 Mn
Dec 31, 2025 549,000.00
Sep 30, 2025 -1.33 Mn
Jun 30, 2025 -4.39 Mn
Mar 31, 2025 -619,000.00
Dec 31, 2024 -219,000.00
Sep 30, 2024 -1.44 Mn
Jun 30, 2024 -847,000.00
Mar 31, 2024 -911,171.00
Dec 31, 2023 -2.14 Mn
Sep 30, 2023 -2.86 Mn
Jun 30, 2023 -840,318.00
Mar 31, 2023 -1.74 Mn
Dec 31, 2022 -1.43 Mn
Sep 30, 2022 -1.77 Mn
Jun 30, 2022 -1.28 Mn
Mar 31, 2022 -1.35 Mn
Dec 31, 2021 -1.57 Mn
Sep 30, 2021 -1.29 Mn
Jun 30, 2021 -1.62 Mn